Zepbound is a newer weight loss medication joining the ranks of Wegovy and Saxenda. It’s a brand name for tirzepatide, which manufacturers also sell as a drug for type 2 diabetes under the name ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.5% in the afternoon session after the company revealed it will offer Eli Lilly's weight-loss medications (Zepbound ...

Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

Hims & Hers Expands Weight Loss Offering, Adds Lilly's Zepbound to Platform The telehealth ... Cartel The commission said that 16 major car manufacturers and the ACEA entered into what it called ...

U.S. stock futures slipped on Monday night as the market awaited clarity from President Donald Trump regarding his tariff ...

Under the agreement, Lexicon will complete certain preclinical activities before Novo Nordisk takes over development, manufacturing ... led to greater weight loss and reductions in food intake ...

It stands out as one of the best growth stocks, boasting a robust pipeline of diabetes and weight loss drugs. Its GLP-1-approved drugs in Zepbound ... billion in four new manufacturing locations ...

While tariffs have triggered market volatility, certain pharmaceutical stocks still present strong investment opportunities.